These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 29567196)
41. Manufacturing and ambient stability of shelf freeze dried bacteriophage powder formulations. Zhang Y; Peng X; Zhang H; Watts AB; Ghosh D Int J Pharm; 2018 May; 542(1-2):1-7. PubMed ID: 29486286 [TBL] [Abstract][Full Text] [Related]
42. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections. Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012 [TBL] [Abstract][Full Text] [Related]
43. Beta-relaxation of insulin molecule in lyophilized formulations containing trehalose or dextran as a determinant of chemical reactivity. Yoshioka S; Miyazaki T; Aso Y Pharm Res; 2006 May; 23(5):961-6. PubMed ID: 16715386 [TBL] [Abstract][Full Text] [Related]
44. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry. Huyge K; Van Reeth K; De Beer T; Landman WJ; van Eck JH; Remon JP; Vervaet C Eur J Pharm Biopharm; 2012 Apr; 80(3):649-56. PubMed ID: 22155763 [TBL] [Abstract][Full Text] [Related]
45. Spray dried VSV-vectored vaccine is thermally stable and immunologically active in vivo. Toniolo SP; Afkhami S; D'Agostino MR; Lichty BD; Cranston ED; Xing Z; Thompson MR Sci Rep; 2020 Aug; 10(1):13349. PubMed ID: 32770018 [TBL] [Abstract][Full Text] [Related]
46. A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery. Focaroli S; Mah PT; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM Int J Pharm; 2019 May; 562():228-240. PubMed ID: 30849470 [TBL] [Abstract][Full Text] [Related]
47. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules. Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447 [TBL] [Abstract][Full Text] [Related]
48. Spray-dried anti-Campylobacter bacteriophage CP30A powder suitable for global distribution without cold chain infrastructure. Carrigy NB; Liang L; Wang H; Kariuki S; Nagel TE; Connerton IF; Vehring R Int J Pharm; 2019 Oct; 569():118601. PubMed ID: 31394183 [TBL] [Abstract][Full Text] [Related]
49. The effect of formulation on spray dried Sabin inactivated polio vaccine. Kanojia G; Ten Have R; Brugmans D; Soema PC; Frijlink HW; Amorij JP; Kersten G Eur J Pharm Biopharm; 2018 Aug; 129():21-29. PubMed ID: 29787800 [TBL] [Abstract][Full Text] [Related]
50. In situ precipitation and vacuum drying of interferon alpha-2a: development of a single-step process for obtaining dry, stable protein formulation. Kumar V; Sharma VK; Kalonia DS Int J Pharm; 2009 Jan; 366(1-2):88-98. PubMed ID: 18824225 [TBL] [Abstract][Full Text] [Related]
51. Stable sugar-based protein formulations by supercritical fluid drying. Jovanović N; Bouchard A; Sutter M; Van Speybroeck M; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W Int J Pharm; 2008 Jan; 346(1-2):102-8. PubMed ID: 17659851 [TBL] [Abstract][Full Text] [Related]
52. Excipient selection for thermally stable enveloped and non-enveloped viral vaccine platforms in dry powders. Toniolo SP; Afkhami S; Mahmood A; Fradin C; Lichty BD; Miller MS; Xing Z; Cranston ED; Thompson MR Int J Pharm; 2019 Apr; 561():66-73. PubMed ID: 30825554 [TBL] [Abstract][Full Text] [Related]
53. Application of disaccharides alone and in combination, for the improvement of stability and particle properties of spray-freeze dried IgG. Daneshmand B; Faghihi H; Amini Pouya M; Aghababaie S; Darabi M; Vatanara A Pharm Dev Technol; 2019 Apr; 24(4):439-447. PubMed ID: 30070161 [TBL] [Abstract][Full Text] [Related]
54. Addition of Pullulan to Trehalose Glasses Improves the Stability of β-Galactosidase at High Moisture Conditions. Teekamp N; Tian Y; Visser JC; Olinga P; Frijlink HW; Woerdenbag HJ; Hinrichs WLJ Carbohydr Polym; 2017 Nov; 176():374-380. PubMed ID: 28927620 [TBL] [Abstract][Full Text] [Related]
55. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01. Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813 [TBL] [Abstract][Full Text] [Related]
56. Surface Composition and Formulation Heterogeneity of Protein Solids Produced by Spray Drying. Wilson NE; Mutukuri TT; Zemlyanov DY; Taylor LS; Topp EM; Zhou QT Pharm Res; 2019 Dec; 37(1):14. PubMed ID: 31873808 [TBL] [Abstract][Full Text] [Related]
58. Enhancing the viability of Lactobacillus rhamnosus GG after spray drying and during storage. Broeckx G; Vandenheuvel D; Henkens T; Kiekens S; van den Broek MFL; Lebeer S; Kiekens F Int J Pharm; 2017 Dec; 534(1-2):35-41. PubMed ID: 28986319 [TBL] [Abstract][Full Text] [Related]
59. Fourier transform infared spectroscopy investigation of protein conformation in spray-dried protein/trehalose powders. French DL; Arakawa T; Li T Biopolymers; 2004 Mar; 73(4):524-31. PubMed ID: 14991670 [TBL] [Abstract][Full Text] [Related]
60. The effect of excipients on the stability and aerosol performance of salmon calcitonin dry powder inhalers prepared via the spray freeze drying process. Poursina N; Vatanara A; Rouini MR; Gilani K; Najafabadi AR Acta Pharm; 2016 Jun; 66(2):207-18. PubMed ID: 27279064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]